FDA Broad Agency Announcement for the Advanced Research and Development of Regulatory Science
The U.S. Food and Drug Administration has an open, continuing announcement to solicit research and development in support of regulatory science and innovation. The Safe Use Initiative welcomes proposals to this announcement which support its mission and goal.
- Read the details of the solicitation announcement (FDABAA-15-00121) (Open as of February 23, 2015)
- Please note Section 8.5 - Studies to increase the safety of post approval drug use